135 related articles for article (PubMed ID: 6846250)
1. A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma.
Rubin J; Sorensen S; Schutt AJ; van Hazel GA; O'Connell MJ; Moertel CG
Am J Clin Oncol; 1983 Jun; 6(3):325-6. PubMed ID: 6846250
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Casper E
Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of 6-diazo-5-oxo-L-norleucine (DON).
Sklaroff RB; Casper ES; Magill GB; Young CW
Cancer Treat Rep; 1980; 64(12):1247-51. PubMed ID: 7471114
[TBL] [Abstract][Full Text] [Related]
4. Phase II study on DON in patients with previously treated advanced lung cancer.
Eagan RT; Frytak S; Nichols WC; Creagan ET; Ingle JN
Cancer Treat Rep; 1982 Aug; 66(8):1665-6. PubMed ID: 6286122
[No Abstract] [Full Text] [Related]
5. Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas.
Earhart RH; Amato DJ; Chang AY; Borden EC; Shiraki M; Dowd ME; Comis RL; Davis TE; Smith TJ
Invest New Drugs; 1990 Feb; 8(1):113-9. PubMed ID: 2188926
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines.
Huber KR; Mayer EP; Mitchell DF; Roberts J
Br J Cancer; 1987 Jun; 55(6):653-6. PubMed ID: 3620309
[No Abstract] [Full Text] [Related]
7. Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.
Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
Cancer Chemother Rep; 1975; 59(3):577-9. PubMed ID: 1203884
[No Abstract] [Full Text] [Related]
8. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.
Catane R; Von Hoff DD; Glaubiger DL; Muggia FM
Cancer Treat Rep; 1979 Jun; 63(6):1033-8. PubMed ID: 380801
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
Kovach JS; Moertel CG; Schutt AJ; Reitemeier RG; Hahn RG
Cancer Chemother Rep; 1973; 57(3):357-9. PubMed ID: 4584486
[No Abstract] [Full Text] [Related]
10. We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of
Lemberg KM; Vornov JJ; Rais R; Slusher BS
Mol Cancer Ther; 2018 Sep; 17(9):1824-1832. PubMed ID: 30181331
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children.
Sullivan MP; Nelson JA; Feldman S; Van Nguyen B
Cancer Chemother Pharmacol; 1988; 21(1):78-84. PubMed ID: 3342470
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses.
Earhart RH; Koeller JM; Davis HL
Cancer Treat Rep; 1982 May; 66(5):1215-7. PubMed ID: 7083223
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
[TBL] [Abstract][Full Text] [Related]
14. Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON).
Rahman A; Smith FP; Luc PT; Woolley PV
Invest New Drugs; 1985; 3(4):369-74. PubMed ID: 4086244
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of alanosine in advanced large bowel carcinoma.
Rubin J; Hineman V; Moertel CG; Schutt AJ; Hahn RG
Am J Clin Oncol; 1983 Apr; 6(2):191-3. PubMed ID: 6829493
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma.
Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
Cancer Chemother Rep; 1975; 59(3):581-3. PubMed ID: 1243107
[No Abstract] [Full Text] [Related]
17. Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.
Marciniak TA; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
Cancer Chemother Rep; 1975; 59(4):761-3. PubMed ID: 1100228
[No Abstract] [Full Text] [Related]
18. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
19. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
Fink DJ; Foye LV
Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
[No Abstract] [Full Text] [Related]
20. A phase II study of chlorozotocin in advanced large bowel carcinoma. A cooperative study between two institutions.
Schutt AJ; Hoth D; Moertel CG; Schein PS; Rubin J; O'Connell MJ
Am J Clin Oncol; 1984 Oct; 7(5):507-11. PubMed ID: 6239538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
